EVOLUS, INC. Investment Income, Interest
EVOLUS, INC. (EOLS) reported Investment Income, Interest of $389.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-01.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2019-05-01
- EVOLUS, INC. investment income, interest for the quarter ending 2019-03-31 was $389.00K.
- EVOLUS, INC. investment income, interest for the quarter ending 2018-03-31 was $0.00.
- EVOLUS, INC. investment income, interest for fiscal 2018 was $203.00K.
- EVOLUS, INC. investment income, interest for fiscal 2017 was $0.00.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 12 month |
|---|---|---|
| 2019-03-31 | $389.00K 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $203.00K 10-K · filed 2019-03-20 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-01 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |